Search Results for "Bioengineering Companies In Boston"

02:18 EDT 25th August 2016 | BioPortfolio

Matching Channels

Boston Scientific

Boston Scientific is a global medical device company, the 8th largest (based on annual sales, which were over $8 billion in 2010). It is the world's second largest maker of heart devices; prod...

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...


The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...


In addition to the world famous Cambridge University, Cambridge and its surrounding area is a hub of globally reaching biotechnology companies. With more than 247 companies, and the high quality res...

Matching News

Most cited papers: bioengineering and agbiotech

We list below the highest-cited papers focusing on bioengineering (metabolic engineering, synthetic biology and bioengineering) and agbiotech from the past 20 years. We recognize there are many more w...

BRIEF-Shenzhen Neptunus Bioengineering says 2015 dividend payment date

May 23 (Reuters) - Shenzhen Neptunus Bioengineering Co Ltd :

IBM Research and Singapore’s Bioengineering Institute develop anti-viral technology

IBM Research and Singapore’s Institute of Bioengineering and Nanotechnology have discovered a new macromolecule with triple-play action to help fight virus infection and drug resistance.

Molecular tools for bioengineering eukaryotic microalgae

(Bentham Science Publishers) The article discusses some of the rapidly developing tools for genome editing and discusses their potential impact on the bioengineering of eukaryotic microalgae.

Boston University enters research agreement with Janssen

(Boston University Medical Center) In an effort to accelerate disease interception approaches to the management of chronic obstructive pulmonary disease (COPD) and lung cancer, Boston University Schoo...

#jobs #lifescience Boston University BioInformatics: MS in Bioinformatics at Boston University – Boston, Massachusetts

// N/A: Boston University BioInformatics: One of the first programs of its kind, the Bioinformatics Graduate Program offers unique interdisciplinary training… Boston, Massachusetts from Job Se...

LIVE 1:40 pm – 3:50 pm 4/26/2016 Fireside Chat: Patients Driving Innovation & Immunotherapy II: Cell Based Therapies & Financing Breakthrough Cancer Companies @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston

LIVE 1:40 pm – 3:50 pm 4/26/2016 Fireside Chat: Patients Driving Innovation & Immunotherapy II: Cell Based Therapies & Financing Breakthrough Cancer Companies @2016 World Medical I...

NewCo Boston to Showcase What's Hot in Innovative Food Production, Health Tech, Energy, ...

BOSTON, MA--(Marketwired - Apr 22, 2016) -  NewCo Boston and the Massachusetts Technology Leadership Council (MassTLC) are hosting the city's first Festival of Innovation Read more...

Matching PubMed Articles

Scanning Electron Microscopic Analysis of Biofilm Formation in Explanted Human Boston Type I Keratoprostheses.

To describe the morphological distribution of host tissue and microbial biofilms on the intraocular surfaces of Boston type I keratoprostheses (KPros) explanted because of corneal melt.

Biotechnology and Bioengineering: Volume 113, Number 8, August 2016.

Biotechnology and Bioengineering: Volume 113, Number 9, September 2016.


To evaluate the ability to visualize and document posterior segment pathology through the Boston keratoprosthesis (KPro) using the Optos P200Tx ultra-widefield (UWF) scanning laser ophthalmoscope.

Eyelid Mass in Boston Keratoprosthesis Type 2.

Boston keratoprosthesis type 2 is used to treat severe corneal blindness secondary to cicatricial or autoimmune ocular surface disease. This case report describes an atypical eyelid mass in a 41-year-...

Search Whole site using Google

Quick Search
Advertisement Advertisement